The Irvine, California firm, Cultivation Technologies, Inc., provides infrastructure, genetics, technology, and branding to the legal medical cannabis industry. With guidance from co-founder and Chief Strategy Officer Justin Beck, Cultivation Technologies, Inc., endeavors through the cannabis industry’s complex regulatory environment. Cultivation Technologies, Inc. reached a milestone with the announcement on June 7, 2018, that it achieved cumulative revenue of $1 million since initiating commercial operations in January 2018. The firm is highly encouraged with its revenue growth in just a few months since the start of operations. It will leverage this momentum for continued growth in the years ahead. Cultivation Technologies Inc.’s Coachella™ Premium brand of vape cartridges and cannabis concentrates has expanded its presence in various dispensaries across California. The brand’s product offering includes all the major concentrate types such as sugar, diamonds, batters, sauces, and shatter. The company’s interim extraction facility, located on its campus in Coachella, can process around 6,000 pounds of biomass monthly. The facility can be further expanded for additional production capacity.
Cultivation Technologies, Inc., was founded in 2015 by entrepreneurs Justin Beck and Rick Probst. Driven by a commitment to develop premium medical-grade cannabis products, Cultivation Technologies, Inc., provides infrastructure, genetics, branding, and technology to the legal cannabis industry. Research indicates that medical cannabis may offer multiple benefits, as explored below. 1. Pain management. Cannabis contains an active chemical known as tetrahydrocannabinol (THC), which possesses pain-relieving properties. Studies suggest that the THC in cannabis can help manage a wide variety of pain, such as chronic and neuropathic pain. One survey published in The Spine Journal reported that one in five patients at the Colorado Spine Center used cannabis to manage pain. 2. Decrease in anxiety. The cannabis plant also contains the active compound cannabidiol (CBD). Research suggests that CBD can positively impact the brain in low doses without triggering intoxication or euphoria. 3. Seizure reduction. Some clinical trials indicate that CBD may effectively reduce the occurrence of seizures in patients with severe epilepsy. In one large-scale trial, as published in the New England Journal of Medicine, nearly 40 percent of participants in the study experienced fewer seizures. 4. Inhibition of Alzheimer’s. Scientific studies show that THC may slow the progression of Alzheimer’s disease by interfering with the production of amyloid plaques, which destroy brain cells.
